Implications of Nε-(Carboxymethy)lysine in altered metabolism of low density lipoproteins in patients with type 2 diabetes and coronary artery disease
The aim of this study is to evaluate the role of the glycoxidation product, Nε-(carboxymethyl)lysine (CML), on the metabolism of LDL which can give rise to increased risks of Coronary Artery Disease (CAD) in Type 2 Diabetes Mellitus (T2DM) patients. Polyclonal anti-CML antibodies, were used for mea...
Main Authors: | Ahmed, K.A.A., Muniandy, S., Ismail, I.S. |
---|---|
Format: | Article |
Published: |
2008
|
Subjects: |
Similar Items
-
N(epsilon)-(Carboxymethyl)lysine and Coronary Atherosclerosis-Associated Low Density Lipoprotein Abnormalities in Type 2 Diabetes: Current Status.
by: Ahmed, K.A., et al.
Published: (2009) -
High-density lipoprotein: relations to metabolic parameters and severity of coronary artery disease.
by: Tornvall, P, et al.
Published: (1996) -
Nε-(carboxymethyl) lysine and corony atherosclerosis-associated low density lipoprotein abnormalities in type 2 diabetes: current status
by: Ismail, I.S., et al.
Published: (2009) -
Low density lipoprotein transport and metabolism in the arterial wall
by: Truskey, George Alexander
Published: (2019) -
REMNANT LIPOPROTEINS AND CORONARY ARTERY DISEASE PROGRESSION
by: Karpe, F, et al.
Published: (1995)